Вклад участника
(новейшие | старейшие) Просмотреть (50 более новых | 50 более старых) (20 | 50 | 100 | 250 | 500)
- 04:51, 3 июня 2024 (разн. | история) . . (+4668) . . Н -Improved-process-of-defeating-nitrite-things-blocking-the-path-inside-GCMS-procedures-for-cannabinoids-r (-Improved-process-of-defeating-nitrite-things-blocking-the-path-inside-GCMS-procedures-for-cannabinoids-r) (текущая)
- 04:48, 30 мая 2024 (разн. | история) . . (+4253) . . Н -involving-sufferers-together-with-principal-biliary-cirrhosis--nd-therefore-amount-to-just-about-the-most-important-analysis-conditions-for-this-condition-p (-involving-sufferers-together-with-principal-biliary-cirrhosis--nd-therefore-amount-to-just-about-the-most-important-analysis-conditions-for-this-condition-p) (текущая)
- 04:54, 28 мая 2024 (разн. | история) . . (+6264) . . Н -Each-of-our-deep--learning-style-rules-can-be-purchased-wide-open-entry-below--httpsgithub-x (-Each-of-our-deep--learning-style-rules-can-be-purchased-wide-open-entry-below--httpsgithub-x) (текущая)
- 04:52, 24 мая 2024 (разн. | история) . . (+5435) . . Н -Among-the-different-biomarkers-microRNAs-represent-a-set-of-noncoding--RNAs-that-regulate-gene-expression-having-been-involved-in-a-wide-variety-of--neoplasia-acting-in-different-oncogenic-pathways-n (-Among-the-different-biomarkers-microRNAs-represent-a-set-of-noncoding--RNAs-that-regulate-gene-expression-having-been-involved-in-a-wide-variety-of--neoplasia-acting-in-different-oncogenic-pathways-n) (текущая)
- 04:56, 23 мая 2024 (разн. | история) . . (+6149) . . Н -Last-but-not-least-many-of-us-identified-mobile-ARGs--against-antibiotics-that-are-presently-beneath-specialized-medical-advancement-or-have--recently-been-authorized-p (-Last-but-not-least-many-of-us-identified-mobile-ARGs--against-antibiotics-that-are-presently-beneath-specialized-medical-advancement-or-have--recently-been-authorized-p) (текущая)
- 05:27, 16 мая 2024 (разн. | история) . . (+4598) . . Н -Myocardial-bovine-collagen-in-cardiovascular-hypertrophy-ng-through-continual-aortic-vomiting-y (-Myocardial-bovine-collagen-in-cardiovascular-hypertrophy-ng-through-continual-aortic-vomiting-y) (текущая)
- 05:19, 10 мая 2024 (разн. | история) . . (+9991) . . Н -The-qualitative-along-with-quantitative-determinati-ldl-cholesterol-as-well-as-the-SmithLemliOpitz-symptoms-through-water-chromatographyparticle-ray-interfacemass-spectrometry-LCPBMS-can-be-presented-k (-The-qualitative-along-with-quantitative-determinati-ldl-cholesterol-as-well-as-the-SmithLemliOpitz-symptoms-through-water-chromatographyparticle-ray-interfacemass-spectrometry-LCPBMS-can-be-presented-k) (текущая)
- 04:50, 8 мая 2024 (разн. | история) . . (+4488) . . Н -Circulation-cytometry-lyophilisedreagent-conduit-regarding-quantifying-sideline-blood-neutrophil-myeloperoxidase-appearance-throughout-myelodysplastic-syndromes-MPOMDSDevelop-method-for-a-analysis-exactness-examine-j (-Circulation-cytometry-lyophilisedreagent-conduit-regarding-quantifying-sideline-blood-neutrophil-myeloperoxidase-appearance-throughout-myelodysplastic-syndromes-MPOMDSDevelop-method-for-a-analysis-exactness-examine-j) (текущая)
- 04:50, 30 апреля 2024 (разн. | история) . . (+6229) . . Н -Bernard-Lyon-One-particular-INSERM-1052-CNRS-5286-Lyon-Portugal-r (-Bernard-Lyon-One-particular-INSERM-1052-CNRS-5286-Lyon-Portugal-r) (текущая)
- 06:48, 22 апреля 2024 (разн. | история) . . (+5860) . . Н -Relating-to-Two-higher-OCRS-had-been-connected-with-a-afterwards-oncoming-nevertheless-eventually-better-intellectual-loss-of-people-changing-to-DAT-in-step-with-CR-j (-Relating-to-Two-higher-OCRS-had-been-connected-with-a-afterwards-oncoming-nevertheless-eventually-better-intellectual-loss-of-people-changing-to-DAT-in-step-with-CR-j) (текущая)
- 05:57, 19 апреля 2024 (разн. | история) . . (+6403) . . Н -Your-elements-have-been-elucidated-in-the-mobile-along-with--molecular-levels-using-transmitting-electron-microscopy-circulation-cytometry-RTqPCR--and-RNAseq-tactics-d (-Your-elements-have-been-elucidated-in-the-mobile-along-with--molecular-levels-using-transmitting-electron-microscopy-circulation-cytometry-RTqPCR--and-RNAseq-tactics-d) (текущая)
- 04:41, 19 апреля 2024 (разн. | история) . . (+4429) . . Н -Traditional-western-mark-investigation-indicated-that-Goalpha-Gqalpha-and-Gsalpha-are-for-this-spot-of-these-Galpha-proteins-shows-that-they-could-modulate-regulated-exocytosis-from-the-pancreatic-acinar-mobile-c (-Traditional-western-mark-investigation-indicated-that-Goalpha-Gqalpha-and-Gsalpha-are-for-this-spot-of-these-Galpha-proteins-shows-that-they-could-modulate-regulated-exocytosis-from-the-pancreatic-acinar-mobile-c) (текущая)
- 11:08, 16 апреля 2024 (разн. | история) . . (+5253) . . Н -Altogether-our-own-studies-present-critical-understanding-concerning-SARSCoV2-vaccineinduced-health-and-really-should-become-very-helpful-to-steer-long-term-vaccination-regimens-as-well-as-individualized-vaccine-methods-t (-Altogether-our-own-studies-present-critical-understanding-concerning-SARSCoV2-vaccineinduced-health-and-really-should-become-very-helpful-to-steer-long-term-vaccination-regimens-as-well-as-individualized-vaccine-methods-t) (текущая)
- 09:56, 12 апреля 2024 (разн. | история) . . (+5311) . . Н -Clinical-study-Signing-up-httpsbeta-s (-Clinical-study-Signing-up-httpsbeta-s) (текущая)
- 07:19, 8 апреля 2024 (разн. | история) . . (+4712) . . Н -FASN-inhibitor-triglyceride-cholesterol-and-also-phosphatidyl-choline-amounts-n (-FASN-inhibitor-triglyceride-cholesterol-and-also-phosphatidyl-choline-amounts-n) (текущая)
- 04:50, 7 апреля 2024 (разн. | история) . . (+4508) . . Н -We-have-in-the-past-demonstrated-that-your-lightcleaved-diazo-dimethoxy-nitro-phenyl-ethyl-diazoDMNPE-team-has-a-amazing-regiospecificity-with-regard-to-adjusting-terminally-phosphorylated-siRNA-l (-We-have-in-the-past-demonstrated-that-your-lightcleaved-diazo-dimethoxy-nitro-phenyl-ethyl-diazoDMNPE-team-has-a-amazing-regiospecificity-with-regard-to-adjusting-terminally-phosphorylated-siRNA-l) (текущая)
- 05:02, 3 апреля 2024 (разн. | история) . . (+4826) . . Н -Even-with-strengthened-defense-for-you-to-SARSCoV2-we-all-validated-a-number-of-postbooster-development-cases-brought-on-by-the-Infectious-Conditions-Society-of-America-t (-Even-with-strengthened-defense-for-you-to-SARSCoV2-we-all-validated-a-number-of-postbooster-development-cases-brought-on-by-the-Infectious-Conditions-Society-of-America-t) (текущая)
- 04:55, 2 апреля 2024 (разн. | история) . . (+6536) . . Н -pertaining-to-Molecular-Image-as-well-as-Translational-Remedies-University-of-Public-Wellness-Xiamen-Global-Society-Outcomes-of-a-WebBased-Questionnaire-q (-pertaining-to-Molecular-Image-as-well-as-Translational-Remedies-University-of-Public-Wellness-Xiamen-Global-Society-Outcomes-of-a-WebBased-Questionnaire-q) (текущая)
- 06:29, 26 марта 2024 (разн. | история) . . (+4750) . . Н -Biochemical-examine-associated-with-heart-valvular-tiss-remoteness-regarding-glycoproteins-and-also-proteoglycans-through-saltinsoluble-components-regarding-bovine-cardiovascular-device-t (-Biochemical-examine-associated-with-heart-valvular-tiss-remoteness-regarding-glycoproteins-and-also-proteoglycans-through-saltinsoluble-components-regarding-bovine-cardiovascular-device-t) (текущая)
- 04:46, 25 марта 2024 (разн. | история) . . (+4122) . . Н -Besides-microneedle-penetration-the-above-described-factors-influenced-the-immune-responses-upon-microneedlebased-vaccination-in-vivo-c (-Besides-microneedle-penetration-the-above-described-factors-influenced-the-immune-responses-upon-microneedlebased-vaccination-in-vivo-c) (текущая)
- 04:40, 18 марта 2024 (разн. | история) . . (+5085) . . Н -The-particular-pathogenesis-of-L-u (-The-particular-pathogenesis-of-L-u) (текущая)
- 03:38, 15 марта 2024 (разн. | история) . . (+4610) . . Н -These-kinds-of-methods-to-visible-feeling-are-generally-simple-and-can-be-applied-to-a-multitude-of-analytes-in-which-luminescent-probes-can-be-purchased-o (-These-kinds-of-methods-to-visible-feeling-are-generally-simple-and-can-be-applied-to-a-multitude-of-analytes-in-which-luminescent-probes-can-be-purchased-o) (текущая)
- 11:47, 14 марта 2024 (разн. | история) . . (+5443) . . Н -Make-sure-you-talk-about-your-accompanying-ICMJE-disclosure-types-for-further-within-immunosuppressed-individuals-plus-healthful-controls-c (-Make-sure-you-talk-about-your-accompanying-ICMJE-disclosure-types-for-further-within-immunosuppressed-individuals-plus-healthful-controls-c) (текущая)
- 08:11, 13 марта 2024 (разн. | история) . . (+6299) . . Н -The-residual-creators-are-convinced-that-your-research-has-been--conducted-without-any-business-or-even-monetary-associations-that-may--be-construed-as-a-potential-discord-appealing-n (-The-residual-creators-are-convinced-that-your-research-has-been--conducted-without-any-business-or-even-monetary-associations-that-may--be-construed-as-a-potential-discord-appealing-n) (текущая)
- 04:40, 8 марта 2024 (разн. | история) . . (+4564) . . Н -Theseinclude-1-the-specific-innate-sensors-that-are-initially-triggered-2-the-kinetics-of-antigen-delivery-and-persistence-3-the-starting-B-cell-receptor-BCR-avidity-and-antigen-valency-and-4-the-memory-B-cell-subsets-that-are-recalled-by-boosters-d (-Theseinclude-1-the-specific-innate-sensors-that-are-initially-triggered-2-the-kinetics-of-antigen-delivery-and-persistence-3-the-starting-B-cell-receptor-BCR-avidity-and-antigen-valency-and-4-the-memory-B-cell-subsets-that-are-recalled-by-boosters-d) (текущая)
- 07:06, 28 февраля 2024 (разн. | история) . . (+10 496) . . Н -Your-purified-biochemically-productive-molecule-had-been-homogeneous-in-SDSPAGE-has-been-found-using-antiXTIantibodies-coupled-with-your-predicted-tryptic-fragment-muscle-size-variety-u (-Your-purified-biochemically-productive-molecule-had-been-homogeneous-in-SDSPAGE-has-been-found-using-antiXTIantibodies-coupled-with-your-predicted-tryptic-fragment-muscle-size-variety-u) (текущая)
- 05:09, 26 февраля 2024 (разн. | история) . . (+5107) . . Н 2-a-enough-protective-tetanus-antitoxin-titre-o (2-a-enough-protective-tetanus-antitoxin-titre-o) (текущая)
(новейшие | старейшие) Просмотреть (50 более новых | 50 более старых) (20 | 50 | 100 | 250 | 500)